Biomerieux Recalls VITEK 2 Gram Negative Test Kits Due to Errors
Biomerieux Inc is recalling VITEK 2 Gram Negative test kits containing colistin because they produced high rates of major errors in susceptibility testing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk of harm (misdiagnosis of antibiotic resistance) where specific injury reports are not detailed in the source text, fitting the 'High' severity criteria for risk-of-harm products.
Plain-English summary
Biomerieux Inc is recalling 1,520,000 VITEK 2 Gram Negative test kits containing colistin (cs01n). The recall was initiated after an investigation demonstrated a high rate of very major errors, where resistant bacterial isolates were incorrectly identified as susceptible. These errors were observed when comparing the test kits to agar dilution and broth-microdilution methods, which are the reference and recommended methods for colistin testing.
The affected products were distributed domestically in North Carolina and internationally to numerous countries, including Argentina, Austria, Brazil, Canada, and the United Kingdom. The specific reference numbers for the affected kits are listed in the agency's recall documentation.
Healthcare facilities and laboratories should stop using the affected VITEK 2 Gram Negative test kits immediately. Users should contact Biomerieux Inc for instructions on how to return the products for a refund or replacement.
The recalled product
- Product
- VITEK 2 Gram Negative test kits containing colistin (cs01n)
- Manufacturer
- Biomerieux Inc
- Hazard
- Affected units
- 1,520,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- REF # (Description): 418114 (AST-GN94)
- 22258 (AST-N102)
- 412605 (AST-N194)
- 412921 (AST-N199)
- 412862 (AST-N201)
- 412863 (AST-N202)
- 412924 (AST-N205)
- 412918 (AST-N210)
- 413061 (AST-N212)
- 413083 (AST-N222)
- 413112 (AST-N225)
- 413171 (AST-N236)
- 413172 (AST-N237)
- 413204 (AST-N239)
- 413205 (AST-N240)
- 413391 (AST-N242)
- 413394 (AST-N245)
- 413397 (AST-N248)
- 413572 (AST-N249)
- 413722 (AST-N253)
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Biomerieux Inc
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · misdiagnosis
See all →- SevereBeckman Coulter MicroScan Panel Update DVD Kits Recalled
FDA (Devices) · 2026-08-12
- HighBlood Analysis System Software Error Can Assign Wrong Patient Name
FDA (Devices) · 2025-01-01
- HighBlood Analysis System Recalled Due to Patient Name Assignment Software Error
FDA (Devices) · 2025-01-01
- HighPhilips Vue PACS Diagnostic Viewer Software Recall for Calculation Errors
FDA (Devices) · 2024-11-27
- HighChange Healthcare Cardiology Hemo Software Recalled for Calculation Errors
FDA (Devices) · 2024-10-23